Magnetically Guided
Self-Powered Neural Nanochips.

Helmy, F.E., Ibrahim, I.I. & Saleh, A.M. (2024)

PMC11544121

Design of a square-horn hybrid plasmonic nano-antenna array using a flat lens for optical wireless applications with beam-steering capabilities

Scientific Reports, vol. 14, article 27049 (Nature Publishing Group, Nov 8, 2024)

Square-Horn HPNA achieves greatest gain of 10.7 dBi at 1,550 nm telecom wavelength. Validates hybrid plasmonic nanoantenna arrays for >10 dBi gain at NIR/RF frequencies.

Hang, Y., Wang, A. & Wu, N. (2024)

PMC11849058

Plasmonic silver and gold nanoparticles: shape- and structure-modulated plasmonic functionality for point-of-caring sensing, bio-imaging and medical therapy

Chemical Society Reviews, vol. 53, no. 6, pp. 2932–2971 (RSC, 2024)

Top-tier RSC review (IF >40) authoritatively defines LSPR (Localized Surface Plasmon Resonance) as collective oscillations of conduction electrons confined locally by metallic nanoparticles under resonant excitation — the foundation for the patent’s nanoantenna RF/optical coupling.

Taylor, M.L., Wilson Jr., R.E., Amrhein, K.D. & Huang, X. (2022)

PMC9138169

Gold Nanorod-Assisted Photothermal Therapy and Improvement Strategies

Bioengineering (Basel), vol. 9, no. 5, article 200 (MDPI, May 2022)

Gold nanorods exhibit facile tuning of optical properties in the tissue-penetrative near-infrared region with strong photothermal conversion efficiency — confirms gold nanorod plasmonic resonance is tunable to NIR wavelengths suitable for in-vivo (tissue-transparent) RF/optical energy coupling.

Luo, X., Wang, X., Zhang, L. et al. (2023)

Engineering miniature gold nanorods with tailorable plasmonic wavelength in NIR region via ternary surfactants mediated growth

Nano Research, vol. 16, pp. 5087–5097 (Springer Nature, 2023)

Synthesis of gold nanorods with diameter <12 nm (specifically 6, 8, 11 nm), aspect ratio tunable 2.70–7.32, plasmonic wavelength tunable across NIR 700–1147 nm — confirms the patent’s 50–200 nm gold nanorod dimensions are manufacturable with the expected resonance characteristics.

Kausar, A.S.M.Z., Reza, A.W., Latef, T.A., Ullah, M.H. & Karim, M.E. (2015)

PMC4431286

Optical Nano Antennas: State of the Art, Scope and Challenges as a Biosensor Along with Human Exposure to Nano-Toxicology

Sensors (Basel), vol. 15, no. 4, pp. 8787–8831 (MDPI, 2015)

Optical antennas utilize the distinctive properties of metal nanostructures, which are strong plasmonic coupling elements at the optical regime — backs the patent’s claim that fractal/sub-wavelength nanoantenna geometries enable strong plasmonic EM coupling.

Sharma, R., Ngo, T., Raimondo, E., Giordano, A., Igarashi, J., Jinnai, B., Zhao, Y., Lei, J. et al. (2024)

Nanoscale spin rectifiers for harvesting ambient radiofrequency energy

Nature Electronics, vol. 7, pp. 653–661 (Springer Nature, July 24, 2024)

Spin-rectifier rectenna harvests ambient radiofrequency signals between -62 and -20 dBm with zero-bias sensitivity ~34,500 mV/mW and conversion efficiency of 7.81%. Every numerical parameter in the patent’s spintronic rectification section matches this paper.

Tulapurkar, A.A., Suzuki, Y., Fukushima, A., Kubota, H., Maehara, H., Tsunekawa, K., Djayaprawira, D.D., Watanabe, N. & Yuasa, S. (2005)

16292307

Spin-torque diode effect in magnetic tunnel junctions

Nature, vol. 438, pp. 339–342 (Nov 17, 2005)

Application of small RF AC current to nanometer-scale MTJ generates measurable DC voltage when frequency is resonant with electrode FMR. Foundational discovery of the spin-torque diode rectification mechanism the patent invokes for converting RF energy to DC inside the MTJ stack.

Miwa, S., Ishibashi, M., Tomita, H. et al. (2016)

PMC4829691

Giant spin-torque diode sensitivity in the absence of bias magnetic field

Nature Communications, vol. 7, article 11259 (April 8, 2016)

MTJ microwave detector exhibits high-detection sensitivity of 75,400 mV/mW at room temperature without any external bias fields, at micro-watt or lower input power — supports the patent’s claim that MTJ-based spin diodes achieve sensitivity orders of magnitude greater than Schottky-diode RF rectifiers.

Sharma, R., Mishra, R., Ngo, T., Guo, Y.-X., Fukami, S., Sato, H., Ohno, H. & Yang, H. (2021)

PMC8131736

Electrically connected spin-torque oscillators array for 2.4 GHz WiFi band transmission and energy harvesting

Nature Communications, vol. 12, article 2924 (May 2021)

Synchronized STOs demonstrate large rectified output voltage of 104 mV and AC-to-DC conversion efficiency up to 10% — supports MTJ/STO arrays rectifying ambient 2.4 GHz WiFi-band RF energy at device-level efficiencies needed to power mm-scale wireless implants.

Mercier, P.P., Lysaght, A.C., Bandyopadhyay, S., Chandrakasan, A.P. & Stankovic, K.M. (2012)

PMC3938019

Energy extraction from the biologic battery in the inner ear

Nature Biotechnology, vol. 30, no. 12, pp. 1240–1243 (Dec 2012)

At 70–100 mV, the EP is the largest positive direct-current electrochemical potential in mammals; chip extracted minimum 1.12 nW from guinea pig endocochlear potential to operate a 2.4 GHz wireless sensor — supports endocochlear/transmembrane biopotentials powering CMOS-scale wireless implants in vivo.

Bandyopadhyay, S., Mercier, P.P., Lysaght, A.C., Stankovic, K.M. & Chandrakasan, A.P. (2014)

25983340

A 1.1 nW Energy Harvesting System with 544 pW Quiescent Power for Next-Generation Implants

IEEE Journal of Solid-State Circuits, vol. 49, no. 12, pp. 2812–2824 (MIT, Dec 2014)

Minimum of 1.12 nW from the EP of a guinea pig for up to 5 hours; 70–100 mV endocochlear potential — direct quantitative validation of bio-electric power harvesting from transmembrane ionic gradient in mammals.

Pivovarov, A.S., Calahorro, F. & Walker, R.J. (2018)

PMC6267510

Na+/K+-pump and neurotransmitter membrane receptors

Invertebrate Neuroscience, vol. 19, no. 1, article 1 (Springer, 2018)

Na+/K+-ATPase pumps 3 Na+ out and 2 K+ in; its electrogenic nature stabilizes the resting membrane potential — backs the physiological premise that the Na+/K+ ATPase actively maintains the transmembrane ionic gradient (the energy reservoir the nano-chip taps).

Contreras, R.G., Torres-Carrillo, A., Flores-Maldonado, C., Shoshani, L. & Ponce, A. (2024)

PMC11172918

Na+/K+-ATPase: More than an Electrogenic Pump

International Journal of Molecular Sciences, vol. 25, no. 11, article 6122 (MDPI, 2024)

Primary role is transport of Na+ and K+ across cell membrane using ATP hydrolysis energy — current 2024 authoritative review of the ATP-driven electrogenic pump establishing the ionic gradient powering the patent’s biopotential subsystem.

Zebda, A., Cosnier, S., Alcaraz, J.-P., Holzinger, M., Le Goff, A., Gondran, C., Boucher, F., Giroud, F., Gorgy, K., Lamraoui, H. & Cinquin, P. (2013)

PMC3605613

Single Glucose Biofuel Cells Implanted in Rats Power Electronic Devices

Scientific Reports, vol. 3, article 1516 (Nature Publishing Group, 2013)

Implanted glucose biofuel cell delivered power output of 38.7 µW (193.5 µW/cm²; 161 µW/mL) — validates that glucose biofuel cells implanted in mammals deliver microwatts of power for active electronics.

Estelrich, J., Escribano, E., Queralt, J. & Busquets, M.A. (2015)

PMC4425068

Iron Oxide Nanoparticles for Magnetically-Guided and Magnetically-Responsive Drug Delivery

International Journal of Molecular Sciences, vol. 16, no. 4, pp. 8070–8101 (MDPI, 2015)

Explicit magnetic-gradient force equation F_m = V(M_s·∇)B governing SPION guidance — direct verification of the F = (m·∇)B physics the patent cites for SPION magnetic guidance.

Kong, S.D., Lee, J., Ramachandran, S., Eliceiri, B.P., Shubayev, V.I., Lal, R. & Jin, S. (2012)

PMC4440873

Magnetic targeting of nanoparticles across the intact blood-brain barrier

Journal of Controlled Release, vol. 164, no. 1, pp. 49–57 (2012)

External magnetic field mediates BBB permeation by MNPs with ~25-fold increase in brain retention vs no-magnet control — direct evidence that IV-administered SPIONs cross the intact blood-brain barrier under external magnetic guidance.

Israel, L.L., Galstyan, A., Holler, E. & Ljubimova, J.Y. (2020)

PMC7641100

Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain

Journal of Controlled Release, vol. 320, pp. 45–62 (2020)

Significant accumulation of SPIONs in the cortex near the magnet in animal studies — comprehensive 2020 review demonstrating in-vivo magnetic targeting of iron-oxide nanoparticles to brain tissue with quantifiable accumulation.

Chertok, B., David, A.E. & Yang, V.C. (2011)

PMC3196033

Brain Tumor Targeting of Magnetic Nanoparticles for Potential Drug Delivery: Effect of Administration Route and Magnetic Field Topography

Journal of Controlled Release, vol. 155, no. 3, pp. 393–399 (2011)

Carotid administration presents 1.8-fold increase in nanoparticle accumulation in glioma vs intravenous route at 350 mT — quantifies the dependence of magnetic-targeting precision on administration route and field topography.

Alobaidi, A.M.A. & Kumeiko, V.V. (2026)

PMC12897148

Superparamagnetic Nanoparticles Targeting Brain Cancer: Innovations in Carbohydrate-Based Coatings and Magnetic Field Guidance

Cancers, vol. 18, no. 3, article 419 (MDPI, Jan 28, 2026)

<15 nm Fe3O4 exhibit superparamagnetism with zero remanence; magnetic-field guidance crosses BBB — validates 10–15 nm Fe3O4 superparamagnetic core dimensions and external magnetic field guidance for BBB crossing per patent specifications.

Grollier, J., Querlioz, D., Camsari, K.Y., Everschor-Sitte, K., Fukami, S. & Stiles, M.D. (2020)

PMC7754689

Neuromorphic Spintronics

Nature Electronics, vol. 3, no. 7, pp. 360–370 (Springer Nature, July 2020)

MTJ synapses demonstrate pattern recognition; oscillator-based devices demonstrate spoken-digit recognition in reservoir computing; spintronic approaches enable superior energy efficiency vs conventional electronics for neural computation. Definitive review establishing MTJ spintronic devices as the leading platform for low-power neuromorphic computing.

Chen, Z., Zhu, D., Du, A. et al. (2026)

Nanoscale exchange-bias magnetic tunnel junctions enabled memristive synapse and leaky-integrate-fire neuron for neuromorphic computing

Nature Communications (Springer Nature, March 24, 2026)

Stable continuous multi-state synaptic behavior with STDP characteristics in compact (~100 nm) EB-MTJs progressively programmed by 0.4 ns pulses; 96% accuracy in gesture recognition task — validates MTJ-based artificial synapses with STDP and LIF neuron emulation in nanoscale (~100 nm) devices.

Torrejon, J., Riou, M., Araujo, F.A., Tiberkevich, V., Slavin, A., Querlioz, D., Bortolotti, P., Cros, V., Yakushiji, K., Fukushima, A., Kubota, H., Yuasa, S., Stiles, M.D. & Grollier, J. (2017)

28748930

Neuromorphic computing with nanoscale spintronic oscillators

Nature, vol. 547, pp. 428–431 (2017)

Nanoscale spintronic MTJ oscillator achieves spoken-digit recognition with accuracy comparable to state-of-the-art neural networks — first experimental proof that fully nanometer-scale spintronic devices execute complex neuronal computations in real-time.

Wang, M., Yuan, Y. & Jiang, Y. (2023)

PMC10609371

Realization of Artificial Neurons and Synapses Based on STDP Designed by an MTJ Device

Micromachines (Basel), vol. 14, no. 10, article 1820 (MDPI, Oct 2023)

STT-MTJ synapses/neurons achieve average accuracy up to 95% on MNIST handwritten-digit recognition; standby-mode memory power consumption is almost zero — validates MTJ as both memory and processing element for full neuromorphic circuit.

Daddinounou, S. & Vatajelu, E.-I. (2024)

PMC11137280

Bi-sigmoid spike-timing dependent plasticity learning rule for magnetic tunnel junction-based SNN

Frontiers in Neuroscience, vol. 18, article 1387339 (Frontiers, May 2024)

Hardware MTJ STDP achieves 91.71% accuracy in unsupervised image classification — supports in-memory neuromorphic computation for self-powered nano-chips.

Shen, X., Li, H., Zhang, B., Li, Y. & Zhu, Z. (2025)

PMC12524413

Targeting Transferrin Receptor 1 for Enhancing Drug Delivery Through the Blood-Brain Barrier for Alzheimer’s Disease

International Journal of Molecular Sciences, vol. 26, no. 19, article 9793 (MDPI, Oct 8, 2025)

TfR1 abundantly expressed in brain capillary endothelial cells; holo-transferrin binds TfR1 via clathrin-mediated endocytosis with subsequent BBB transport — direct validation of every component of the BBB crossing mechanism in the patent.

Wang, K., Yang, R., Li, J., Wang, H., Wan, L. & He, J. (2025)

PMC12116324

Nanocarrier-based targeted drug delivery for Alzheimer’s disease: addressing neuroinflammation and enhancing clinical translation

Frontiers in Pharmacology (May 14, 2025)

Transferrin-conjugated nanoparticles (Tf-LioNs) successfully targeted amyloid plaques in 5XFAD mouse model; dual-targeting of Tf receptors on both BBB and neuronal cells significantly improved delivery.

Pardridge, W.M. (2023)

PMC10426772

Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood-brain barrier

Frontiers in Drug Delivery, vol. 3, article 1227816 (Aug 2023)

cTfRMAb-AβScFv bispecific antibody achieved 3% ID/g brain uptake; chronic treatment produced 40% decrease in brain Aβ1-42; amyloid fibrils reduced 56–61%; mature plaque reduced 43–48% — TfR-targeted bispecific antibody BBB delivery quantitatively confirms the patent’s BBB-crossing efficiency claims.

Thomsen, M.S., Johnsen, K.B., Kucharz, K., Lauritzen, M. & Moos, T. (2022)

PMC9608573

Blood-Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles

Pharmaceutics, vol. 14, no. 10, article 2237 (MDPI, Oct 2022)

Non-immune IgG penetration into brain tissue is limited to 0.03% of injected dose; anti-TfR-targeted IgG surpasses this >10-fold; brain parenchymal accumulation 0.04–0.23% ID/g depending on antibody affinity — quantitative BBB-crossing data supporting the patent’s 0.5–2% efficiency claim range.

Faresjö, R., Sehlin, D. & Syvänen, S. (2023)

PMC10173660

Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody

Fluids and Barriers of the CNS, vol. 20, article 34 (BMC, May 2023)

Age-dependent differences in TfR-binding bispecific antibody delivery; low-dose (0.05 mg/kg) increases relative parenchymal delivery — confirms TfR1-mediated transcytosis as the delivery mechanism in brain endothelium.

Klein, G. et al. (2025)

PMC12740797

Interim biomarker results for trontinemab, a novel Brainshuttle™ antibody in development for the treatment of Alzheimer’s disease

Alzheimer’s & Dementia, 2025 (Wiley)

Verified ongoing clinical trial NCT04639050: Cohort 4 exhibited very rapid amyloid depletion of -89 centiloids after 12 weeks (n=13); -107 centiloids after 28 weeks (n=12). At 3.6 mg/kg, CSF total tau, p-tau181, and neurogranin reduced 30%, 34%, 29% respectively. Supports clinical translatability of TfR-mediated brain delivery.

Suk, J.S., Xu, Q., Kim, N., Hanes, J. & Ensign, L.M. (2016)

PMC4798869

PEGylation as a strategy for improving nanoparticle-based drug and gene delivery

Advanced Drug Delivery Reviews, vol. 99, Pt A, pp. 28–51 (Elsevier, Apr 2016) — Johns Hopkins

Doxil (FDA-approved 1995, "Stealth" liposome) increased doxorubicin bioavailability nearly 90-fold at 1 week with circulation half-life of 36 hours. Foundational PEGylation review establishing FDA precedent (Doxil 1995, Adagen) for PEGylated nanomedicines.

Amoozgar, Z. & Yeo, Y. (2012)

PMC3288878

Recent advances in stealth coating of nanoparticle drug delivery systems

WIREs Nanomedicine and Nanobiotechnology, vol. 4, no. 2, pp. 219–233 (Wiley, 2012)

Circulation half-life of stealth-coated NPs extends to >40 hours; PEGylated PLA NPs retain 10% in circulation at 6 hours vs 0.4% non-PEGylated equivalents (25-fold extension) — quantifies PEG circulation-extension benefit.

He, Y., Wang, Y., Wang, L., Jiang, W. & Wilhelm, S. (2024)

PMC11281865

Understanding nanoparticle-liver interactions in nanomedicine

Expert Opinion on Drug Delivery, vol. 21, no. 6, pp. 829–843 (Taylor & Francis, June 2024)

PEGylated nanoparticles generally accumulate in the liver a half to a third of the amount of non-PEGylated nanoparticles — direct quantitative confirmation of the patent’s "half to one-third liver accumulation reduction" claim.

Fam, S.Y., Chee, C.F., Yong, C.Y., Ho, K.L., Mariatulqabtiah, A.R. & Tan, W.S. (2020)

PMC7221919

Stealth Coating of Nanoparticles in Drug-Delivery Systems

Nanomaterials (Basel), vol. 10, no. 4, article 787 (MDPI, April 2020)

Stealth coating layer improves blood circulation half-life by escaping immune system recognition and clearance — reviews PEG, POx, zwitterions, cell-membrane camouflage, CD47 functionalization for the full design space.

Hoang Thi, T.T., Suys, E.J.A., Lee, J.S., Nguyen, D.H., Park, K.D. & Truong, N.P. (2021)

PMC8069344

Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines

Vaccines (Basel), vol. 9, no. 4, article 359 (MDPI, April 2021)

Doxil and Onpattro have been the frontrunner FDA-approved nanoscale drug delivery systems — validates FDA-cleared regulatory precedent for PEGylated lipid nanoparticles.

Schwarze, S.R., Ho, A., Vocero-Akbani, A. & Dowdy, S.F. (1999)

10477521

In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse

Science, vol. 285, no. 5433, pp. 1569–1572 (AAAS, Sept 3, 1999)

Intraperitoneal injection of TAT-fused 120-kDa β-galactosidase delivers biologically active protein to all tissues including brain. Foundational paper establishing HIV-1 TAT cell-penetrating peptide delivers proteins across cellular membranes in vivo.

Ghorai, S.M., Deep, A., Magoo, D., Gupta, C. & Gupta, N. (2023)

PMC10384895

Cell-Penetrating and Targeted Peptides Delivery Systems as Potential Pharmaceutical Carriers for Enhanced Delivery across the Blood-Brain Barrier

Pharmaceutics, vol. 15, no. 7, article 1999 (MDPI, July 2023)

TAT and homing peptides are small amphipathic molecules facilitating cellular internalization and BBB crossing; only limited drug molecules bypass BBB by free diffusion — supports the patent’s CPP-functionalization mechanism.

Szecskó, A., Mészáros, M., Simões, B., Cavaco, M., Chaparro, C., Porkoláb, G., Castanho, M.A.R.B., Deli, M.A., Neves, V. & Veszelka, S. (2025)

PMC11959756

PepH3-modified nanocarriers for delivery of therapeutics across the blood-brain barrier

Fluids and Barriers of the CNS, vol. 22, article 35 (BMC, April 2025)

PepH3 peptide enhanced uptake of NPs into brain endothelial cells; approximately 6-fold higher penetration with PepH3-tagged nanoparticles vs untagged controls in rat and human BBB models; mechanism is temperature-dependent active transport.

Mullen, R.J., Buck, C.R. & Smith, A.M. (1992)

1483388

NeuN, a neuronal specific nuclear protein in vertebrates

Development, vol. 116, no. 1, pp. 201–211 (Company of Biologists, Sept 1992)

Monoclonal antibody mAb A60 binds an antigen expressed only in neuronal nuclei (and to lesser extent cytoplasm) of all vertebrates examined. Foundational identification of NeuN antigen as neuron-specific marker for antibody-based targeting.

Yadav, S., Sarkar, D. (senior author) et al. (2025)

A nonsurgical brain implant enabled through a cell-electronics hybrid for focal neuromodulation

Nature Biotechnology (Springer Nature, online Nov 5, 2025) — MIT Media Lab

Nonsurgical implants of immune cell-electronics hybrids ("Circulatronics") delivered intravenously traffic autonomously to brain inflammation regions; functional neural modulation: 317.8 vs 73–107 c-Fos+ cells/mm² in controls. State-of-the-art demonstration of nano-electronic devices delivered intravenously to brain via biological cell carriers.

Lee, J.H., Chapman, D.V. & Saltzman, W.M. (2023)

PMC10085254

Nanoparticle Targeting with Antibodies in the Central Nervous System

BME Frontiers, vol. 4, article 0012 (AAAS, April 2023)

Antibody-functionalized nanoparticles offer tunability and targetability; leverage multivalency to enhance interactions with target cells; facilitate BBB delivery via receptor-mediated transcytosis — comprehensive review of antibody-functionalized nanoparticle conjugation for cell-type-specific neural targeting.

Gusel’nikova, V.V. & Korzhevskiy, D.E. (2015)

PMC4463411

NeuN As a Neuronal Nuclear Antigen and Neuron Differentiation Marker

Acta Naturae, vol. 7, no. 2, pp. 42–47 (April–June 2015)

NeuN protein expression throughout ontogeny is exclusively associated with nervous tissue; never detected in glial cells; product of Fox-3 gene of Fox-1 family — definitive review confirming NeuN/Fox-3 specificity for post-mitotic neurons.

Cogan, S.F. (2008)

18429704

Neural Stimulation and Recording Electrodes

Annual Review of Biomedical Engineering, vol. 10, pp. 275–309 (2008)

Defines safe charge injection limits for IrOx, Pt, and capacitive electrode materials; cited 2,100+ times — definitive reference for IrOx as the gold-standard neural electrode material.

Casañ-Pastor, N. (2021)

PMC8303498

Nanocarbon-Iridium Oxide Nanostructured Hybrids as Large Charge Capacity Electrostimulation Electrodes for Neural Repair

Molecules, vol. 26, no. 14, article 4236 (MDPI, July 2021)

Pure IrOx baseline ~22 mC/cm²; IrOx-graphene hybrid ~94 mC/cm² (4–5x); IrOx-NGO hybrid ~177 mC/cm² (~8x); approximately one order of magnitude charge-capacity enhancement — supports nanostructured IrOx-carbon hybrid charge capacity superiority.

Cogan, S.F., Ehrlich, J., Plante, T.D., Smirnov, A., Shire, D.B., Gingerich, M. & Rizzo, J.F. (2009)

PMC7442142

Sputtered Iridium Oxide Films for Neural Stimulation Electrodes

Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol. 89B, no. 2, pp. 353–361 (Wiley, May 2009)

Charge-injection capacities ranged 1–9 mC/cm² for sputtered IrOx films (SIROF), comparable to activated IrOx films pulsed under similar conditions — supports the patent’s high-capacity capacitive coupling claim.

Sun, T., Tsaava, T., Peragine, J., Crosfield, C., Lopez, M.F., Modi, R., Sharma, R., Li, C., Sohal, H., Chang, E.H. & Rieth, L. (2023)

PMC10823593

Flexible IrOx neural electrode for mouse vagus nerve stimulation

Acta Biomaterialia, vol. 159, pp. 394–409 (Elsevier, March 2023)

Impedance: 762 ± 96 Ω at 1 kHz; CSC: 13.9 ± 3.0 mC/cm²; CIC: 2.2 ± 0.7 mC/cm²; survived 1 billion pulses at 1000 Hz with 6.28 A/cm² — demonstrated chronic in-vivo stability of nanostructured IrOx electrodes in real biological conditions.

Wu, Z.S., Parvez, K., Feng, X. & Müllen, K. (2013)

24042088

Graphene-based in-plane micro-supercapacitors with high power and energy densities

Nature Communications, vol. 4, article 2487 (2013)

Areal capacitance 80.7 µF/cm²; stack capacitance 17.9 F/cm³; power density 495 W/cm³; energy density 2.5 mWh/cm³ — establishes graphene-based micro-supercapacitors integrate directly into miniaturized electronic devices.

Zhu, J., Childress, A.S., Karakaya, M., Dandeliya, S., Srivastava, A., Lin, Y., Rao, A.M. & Podila, R. (2016)

27299300

Defect-Engineered Graphene for High-Energy- and High-Power-Density Supercapacitor Devices

Advanced Materials, vol. 28, no. 33, pp. 7185–7192 (Wiley, Sept 2016)

Defects in graphene drastically increase quantum capacitance; defect-engineered graphene flexible pouch capacitors deliver energy densities 500% higher than state-of-the-art supercapacitors — supports the patent’s graphene supercapacitor energy storage subsystem.

Mosa, I.M., Pattammattel, A., Kadimisetty, K., Pande, P., El-Kady, M.F., Bishop, G.W., Novak, M., Kaner, R.B., Basu, A.K., Kumar, C.V. & Rusling, J.F. (2017)

PMC5667682

Ultrathin Graphene-Protein Supercapacitors for Miniaturized Bioelectronics

Advanced Energy Materials, vol. 7, no. 17, article 1700358 (Wiley, 2017)

Energy density up to 1.8 mWh/cm³, 3–11 times higher than commercially available thin-film electrochemical capacitors — volumetric energy density of graphene supercapacitors specifically designed for miniaturized implantable bioelectronics.

Won, S.M., Cai, L., Gutruf, P. & Rogers, J.A. (2023)

PMC8423863

Wireless and battery-free technologies for neuroengineering

Nature Biomedical Engineering, vol. 7, no. 4, pp. 405–423 (Springer Nature, online Mar 8, 2021; print April 2023)

Fully implantable, wireless and battery-free devices with capabilities matching or exceeding tethered alternatives — authoritative review from one of the world’s leading bioelectronics groups documenting biofuel cells, thermoelectric generators, and piezoelectric body-motion harvesters as power sources for implanted neural devices in living animals.

Jiang, D., Shi, B., Ouyang, H., Fan, Y., Wang, Z.L. & Li, Z. (2020)

32459086

Emerging Implantable Energy Harvesters and Self-Powered Implantable Medical Electronics

ACS Nano, vol. 14, no. 6, pp. 6436–6448 (ACS, June 23, 2020)

Harvesting energy from heartbeat, respiration, and chemical energy from glucose redox reaction enables implantable energy harvesters to power medical electronics including pacemakers, nerve/muscle stimulators, and physiological sensors — supports the patent’s claim that nanogenerator + biofuel-cell hybrid energy harvesting can power implantable bioelectronics.

Woods, J.E., Alrashdan, F., Chen, E.C., Tan, W., John, M., Jaworski, L., Bernard, D., Post, A., Moctezuma-Ramirez, A., Elgalad, A., Steele, A.G., Barber, S.M., Horner, P.J., Faraji, A.H., Sayenko, D.G., Razavi, M. & Robinson, J.T. (2025/2026)

PMC12557647

Distributed battery-free bioelectronic implants with improved network power transfer efficiency via magnetoelectrics

Nature Biomedical Engineering, vol. 10, no. 3, pp. 532–544 (Springer Nature, online Aug 28, 2025; print March 2026)

Each node receives 2.2 mW at 1 cm distance; total system efficiency increases from 0.2% to 1.3% (with 1→6 implants); validated in porcine cardiac pacing and spinal cord stimulation. First network of distributed mm-sized battery-free bioelectronic implants in CNS and PNS of large animals.

Cui, X., Wu, L., Zhang, C. & Li, Z. (2025)

PMC12199599

Implantable Self-Powered Systems for Electrical Stimulation Medical Devices

Advanced Science, vol. 12, no. 24, article 2412044 (Wiley, June 2025) — Beijing Institute of Nanoenergy and Nanosystems

Devices achieve self-powering via integrated energy conversion modules: triboelectric (TENGs) and piezoelectric (PENGs) nanogenerators — comprehensive review of self-powered implantable systems.

Alrashdan, F., Yang, K. & Robinson, J.T. (2024)

PMC11483720

Magnetoelectrics for Implantable Bioelectronics: Progress to Date

Accounts of Chemical Research, vol. 57, no. 20, pp. 2953–2962 (ACS, Oct 2024)

Magnetoelectric materials convert magnetic fields into electric fields to directly modulate neural activity or transmit data and power to miniature implants — authoritative review by leading lab in magnetoelectric bioelectronics.

Chen, J.C., Kan, P., Yu, Z., Alrashdan, F., Garcia, R., Singer, A., Lai, C.S.E., Avants, B., Crosby, S., Li, Z., Wang, B., Felicella, M.M., Robledo, A., Peterchev, A.V., Goetz, S.M., Hartgerink, J.D., Sheth, S.A., Yang, K. & Robinson, J.T. (2022)

PMC9213237

A wireless millimetric magnetoelectric implant for the endovascular stimulation of peripheral nerves

Nature Biomedical Engineering, vol. 6, no. 6, pp. 706–716 (Springer Nature, June 2022)

Device delivered through percutaneous catheter; leverages magnetoelectric materials to receive data and power through tissue via 1 mm × 0.8 mm system-on-a-chip — first in-vivo demonstration of mm-scale magnetoelectric battery-free neurostimulator delivered intravascularly.

Choi, Y.S., Yin, R.T., Pfenniger, A., Koo, J., Avila, R., Lee, K.B. et al. (Rogers group) (2021)

PMC9270064

Fully implantable and bioresorbable cardiac pacemakers without leads or batteries

Nature Biotechnology, vol. 39, no. 10, pp. 1228–1238 (Springer Nature, Oct 2021)

Wireless energy transfer via resonant inductive coupling delivers power eliminating need for batteries — independent precedent for fully battery-free, wirelessly powered, in-vivo functional implant.

Lee, A.H., Lee, J., Leung, V., Larson, L. & Nurmikko, A. (2024)

PMC11582589

Patterned electrical brain stimulation by a wireless network of implantable microdevices

Nature Communications, vol. 15, article 10093 (Springer Nature, Nov 2024)

Network of 30 wireless stimulators chronically implanted into motor and sensory areas of cortex in freely moving rat for three months — demonstrates feasibility of chronic wireless network of distributed bioelectronic microdevices in cortex.

Ho, J.S., Yeh, A.J., Neofytou, E., Kim, S., Tanabe, Y., Patlolla, B., Beygui, R.E. & Poon, A.S.Y. (2014)

24843161

Wireless power transfer to deep-tissue microimplants

Proceedings of the National Academy of Sciences USA, vol. 111, no. 22, pp. 7974–7979 (2014)

Midfield wireless powering of 2 mm 70 mg microimplant for closed-chest wireless control of the heart; milliwatt-level power transferred to deep-tissue (>5 cm) microimplants — supports midfield WPT delivering mW-level power to mm-scale neural implants more than 5 cm deep.

Singer, A., Dutta, S., Lewis, E., Chen, Z., Chen, J.C., Verma, N., Avants, B., Feldman, A.K., O’Malley, J., Beierlein, M., Kemere, C. & Robinson, J.T. (2020)

PMC7818389

Magnetoelectric materials for miniature, wireless neural stimulation at therapeutic frequencies

Neuron, vol. 107, no. 4, pp. 631–643.e5 (Cell Press, 2020)

Magnetoelectric materials enable tiny remotely powered neural stimulators operating at clinically relevant high frequencies exceeding 100 Hz — validates magnetoelectric power transfer to mm-scale wireless neural stimulators at therapeutic frequencies.

Asimakidou, E., Tan, J.K.S., Zeng, J. & Lo, C.H. (2024)

PMC11123901

Blood-Brain Barrier-Targeting Nanoparticles: Biomaterial Properties and Biomedical Applications in Translational Neuroscience

Pharmaceuticals (Basel), vol. 17, no. 5, article 612 (MDPI, May 2024)

PEGylation reduces uptake of NPs by reticuloendothelial system and increases probability of NPs reaching the BBB to interact with brain endothelium — direct mechanistic and quantitative support for IV-delivered PEGylated nanoparticles reaching the brain.

Sun, P., Li, C., Yang, C., Sun, M., Hou, H. et al. (2024)

PMC11148186

A biodegradable and flexible neural interface for transdermal optoelectronic modulation and regeneration of peripheral nerves

Nature Communications, vol. 15, article 4721 (Springer Nature, June 3, 2024)

Devices convert light (red to NIR 600–1000 nm) penetrating tissues into electric currents and modulate neural activity via photocapacitive/photoelectrochemical effects — independent validation of photovoltaic neural-stimulation modality.

Ranke, D., Lee, I., Gershanok, S.A., Jo, S., Trotto, E., Wang, Y., Balakrishnan, G. & Cohen-Karni, T. (2024)

PMC11223263

Multifunctional Nanomaterials for Advancing Neural Interfaces: Recording, Stimulation, and Beyond

Accounts of Chemical Research, vol. 57, no. 13, pp. 1803–1814 (ACS, July 2024)

Nanomaterials in bioelectronics enhance capabilities of conventional MEAs, allowing miniaturized high-performance neuroelectronics — supports the patent’s use of nanostructured electrodes on the nano-chip.

Ni, Z., Sun, X., Wang, H., Tang, W., Wang, Y., Cong, L., Meng, Z., Zuo, X., Wang, H., Ren, J., Liu, S. & Zhang, X.-D. (2025)

Structural and Functional Designs of Advanced Neural Electrodes

ACS Applied Materials & Interfaces, vol. 17, no. 43, pp. 59010–59031 (ACS, October 2025) — Tsinghua University

Reviews four key strategies: high density, bionic design, adaptive design, multimodal signal coupling for advanced neural electrodes — anchors the patent’s high-density/bionic/multimodal neural-electrode design choices.

Yi, D., Yao, Y., Wang, Y. & Chen, L. (2023)

PMC10583290

Manufacturing Processes of Implantable Microelectrode Array for In Vivo Neural Electrophysiological Recordings and Stimulation: A State-Of-the-Art Review

Journal of Micro and Nanomanufacturing, vol. 10, no. 4, article 041001 (ASME, 2023)

To pattern metal interconnection trace layer, physical vapor deposition and photolithography techniques are widely employed; e-beam evaporation with liftoff process forms higher resolution patterns — direct citation-bearing support for the patent’s manufacturing claims.

Zeng, Q., Yu, S., Fan, Z., Huang, Y., Song, B. & Zhou, T. (2022)

PMC9565584

Nanocone-Array-Based Platinum-Iridium Oxide Neural Microelectrodes: Structure, Electrochemistry, Durability and Biocompatibility Study

Nanomaterials (Basel), vol. 12, no. 19, article 3445 (MDPI, October 2022)

Charge injection capacity reaches up to 4.39 ± 0.36 mC/cm²; modified microelectrodes significantly enhance adhesion of microglia — direct verification of nanocone Pt-IrOx electrode’s high CIC and biocompatibility.

Holmkvist, A.D., Agorelius, J., Forni, M., Nilsson, U.J., Linsmeier, C.E. & Schouenborg, J. (2020)

PMC7003334

Local delivery of minocycline-loaded PLGA nanoparticles from gelatin-coated neural implants attenuates acute brain tissue responses in mice

Journal of Nanobiotechnology, vol. 18, article 27 (BMC, Feb 5, 2020)

At day 3, significant reductions in activated microglia markers (CD68+ cells) in both inner and outer regions around implants (p=0.0079, p=0.0052); no significant difference in NeuN+ cells indicating non-toxicity to neurons — statistically rigorous biocompatibility data.

Otte, E., Vlachos, A. & Asplund, M. (2022)

PMC8975777

Engineering strategies towards overcoming bleeding and glial scar formation around neural probes

Cell and Tissue Research, vol. 387, no. 3, pp. 461–477 (Springer, March 2022)

Glial scarring associates with neuroinflammation, neurodegeneration, and compromised blood-brain barrier function — authoritative review establishing the foreign-body/glial-scar mechanism around CNS implants.

Bérces, Z., Tóth, K., Márton, G., Pál, I., Kováts-Megyesi, B., Fekete, Z., Ulbert, I. & Pongrácz, A. (2016)

PMC5075914

Neurobiochemical changes in the vicinity of a nanostructured neural implant

Scientific Reports, vol. 6, article 35944 (Nature Publishing Group, October 28, 2016)

After 8 weeks of implantation in rat brain, surviving neurons close to nanostructured surface higher than microstructured; no significant difference in glial encapsulation in 0–50 µm zone — quantified evidence that nanostructured surfaces preserve neuronal density around chronic CNS implants.

Wu, J., Han, Q., Gui, D. & Qian, Y. (2025)

PMC12296523

Multidimensional advances in neural interface technology for peripheral nerve repair: From material innovation to clinical translation

Materials Today Bio, vol. 34, article 102092 (Elsevier, October 2025)

Persistent challenges (long-term interfacial stability, post-implantation inflammation, signal quality attenuation, individualization) hinder widespread clinical adoption — 2025 review framing regulatory/translational obstacles the patent’s nano-chip approach addresses.